Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

All

ATC	Name	B/G	Ingredients	Form	Price
J05AR18	GENVOYA	B	Emtricitabine - 200mg, Tenofovir alafenamide - 10mg, Elvitegravir - 150mg, Cobicistat - 150mg	Tablet, film coated	77,789,650 L.L
D07CC02	GENTACORT-FC	G	Fluocinolone acetonide - 0.01%, Clotrimazole - 1%, Gentamicin (sulfate) - 0.1%	Cream	302,365 L.L
J07BB01	GC FLU QUADRIVALENT INFLUENZA VACCINE	G	Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml	Injectable suspension	791,523 L.L
C05CA54	GINKOR FORT	B	Heptaminol HCl - 0.300g, Troxerutine - 0.300g, Ginkgo biloba extract - 0.014g	Capsule	681,328 L.L
B03AD03	GYNO-TARDYFERON	B	Folic acid - 0.35mg, Ferrous (sulfate) - 80mg	Tablet, sugar coated, slow release	819,744 L.L
R02AA05	GOLASEPTINE-LIDOCAINE	G	Chlorhexidine HCl - 5mg, Lidocaine HCl - 1mg	Tablet, chewable	736,426 L.L
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml	Injectable suspension	14,139,396 L.L
A02BX13	GAVISCON	B	Sodium alginate - 500mg/10ml, Sodium bicarbonate - 267mg/10ml, Calcium (carbonate) - 160mg/10ml	Liquid	295,645 L.L
A02BX13	GAVISCON INFANT	B	Sodium alginate - 225mg, Magnesium alginate - 87.5mg	Powder for suspension	710,893 L.L
A02BX13	GAVISCON ADVANCE ANISEED FLAVOR	B	Sodium alginate - 1000mg/10ml, Potassium hydrogen carbonate - 200mg/10ml	Suspension	514,692 L.L
A02BX13	GAVISCON DOUBLE ACTION MINT	B	Sodium alginate - 250mg, Sodium bicarbonate - 106.5mg, Calcium (carbonate) - 187.5mg	Tablet, chewable	456,906 L.L
A02BX13	GAVISCON DOUBLE ACTION MINT	B	Sodium alginate - 500mg/10ml, Sodium bicarbonate - 213mg/10ml, Calcium (carbonate) - 325mg/10ml	Suspension	542,912 L.L
A02BX13	GAVISCON DOUBLE ACTION	B	Sodium alginate - 500mg, Sodium bicarbonate - 213mg, Calcium (carbonate) - 325mg	Suspension	517,379 L.L
A02BX13	GAVISCON PEPPERMINT LIQUID	B	Sodium alginate - 250mg/10ml, Sodium bicarbonate - 133.5mg/10ml, Calcium (carbonate) - 80mg/10ml	Suspension	393,746 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 150mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	395,090 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	395,090 L.L
C09DA04	GIZLAN-PLUS	G	Irbesartan - 300mg, Hydrochlorothiazide - 25mg	Tablet, film coated	768,678 L.L
G01AA51	GYNAMEND	G	Nystatin - 100,000IU, Neomycin (sulfate) - 35,000IU, Polymyxin B sulfate - 35,000IU	Capsule, soft	345,560 L.L
M02AA15	GROFENAC	G	Diclofenac sodium - 1%	Emulsion Gel	314,459 L.L
N02BE51	GENTLE RELIEF	G	Paracetamol - 325mg, Ibuprofen - 400mg, Famotidine - 20mg	Tablet	184,106 L.L
D02AX	GLYCERINE	G	Glycerol -	Liquid	163,821 L.L
S01ED51	GANFORT	B	Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml	Drops solution	950,097 L.L
S01ED51	GANFORT	B	Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml	Drops solution	950,097 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 500mg, Glibenclamide - 2.5mg	Tablet, film coated	563,663 L.L
A10BD02	GLYSTOR PLUS	G	Metformin HCl - 500mg, Glibenclamide - 2.5mg	Tablet, film-scored	533,697 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 500mg, Glibenclamide - 5mg	Tablet, film coated	775,971 L.L
A10BD02	GLYSTOR PLUS	G	Metformin HCl - 500mg, Glibenclamide - 5mg	Tablet, film-scored	691,119 L.L
A10BD02	GLUCOVANCE	B	Metformin HCl - 1000mg, Glibenclamide - 5mg	Tablet, film coated	1,006,220 L.L
A10BD02	GLIBOMET	B	Metformin HCl - 400mg, Glibenclamide - 5mg	Tablet, film coated	462,282 L.L
G03CC06	GYNOFLOR	B	Estriol - 0.03mg, Lactobacillus acidophillus - 10 MIU	Tablet	813,025 L.L